Positive Effect of AI on the Medical Industry During the Epidemic

Zheng Gao; Jialin Liang; Jiasen Liang

doi:10.54097/hbem.v14i.8976

Authors

Zheng Gao
Jialin Liang
Jiasen Liang

DOI:

https://doi.org/10.54097/hbem.v14i.8976

Keywords:

AI, medical, influence, valuation.

Abstract

In last three years, the COVID-19 has swept around the world. Under the impact of the epidemic, the medical industry must face plenty of new challenges. To be specific, at this time, AI medical came into being and helped many fields. This paper will use PEST, literature review, quantitative analysis, and other methods to investigate the current situation of AI medicine and the two essential areas of AI medicine, i.e., the market of AI medicine and AI imaging and the financing of AI medicine. Based on the analysis, AI medical treatment is an emerging and popular field in the market. It has carried out technological innovation in many fields, improved efficiency, and reduced costs. According to the analysis, the financing situation of Ai Medical is optimistic, the total amount is rising, and the market is also maturing. AI Healthcare has a very positive impact on all enterprises involved. These results will help investors better understand this emerging industry and shed light on guiding further exploration of AI implementation in medical industry.

Downloads

Download data is not yet available.

References

Zhou Y, Wang F, Tang J, et al. Artificial intelligence in COVID-19 drug repurposing. The Lancet Digital Health, 2020, 2 (12): e667 - e676.

Jin S, Wang B, Xu H, et al. AI-assisted CT imaging analysis for COVID-19 screening: Building and deploying a medical AI system in four weeks. MedRxiv, 2020: 2020.03. 19.20039354.

Savoia D. New antimicrobial approaches: reuse of old drugs. Current drug targets, 2016, 17 (6): 731 - 738.

Peng X, Lin M M, Huang Y. The global AI pharmaceutical industry is accelerating amid the pandemic. China Academic Journal Electronic Publishing House, 2022.

Chen T, Cao. X. P, Pharmaceutical companies explore the way AI Pharmaceutical. China Business News, 2022 - 8 - 15 (B16).

Zhang Y D. Leading companies have entered into "AI pharmaceutical" to accelerate the landing. China Electronic News, 2021 - 11 - 26 (006).

Kononenko I. Machine learning for medical diagnosis: history, state of the art and perspective. Artificial Intelligence in medicine, 2001, 23 (1): 89 - 109.

Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism, 2017, 69: S36 - S40.

Zhang M, Wang Y, Ding Q, et al. Application of artificial intelligence image-assisted diagnosis system in chest CT examination of COVID-19. ResearchGate, 2020.

Balyen L, Peto T. Promising artificial intelligence-machine learning-deep learning algorithms in ophthalmology. The Asia-Pacific Journal of Ophthalmology, 2019, 8 (3): 264 - 272.

Guo Y, Ren X, Chen Y, et al. Artificial intelligence meets Chinese medicine. Chinese journal of integrative medicine, 2019, 25: 648 - 653.